^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Imai T, Sugawara T, Nishiyama A, Shimada R, Ohki R, Seki N, Sagara M, Ito H, Yamauchi M, Hori T (Jun 1997). "The structure and organization of the human NPAT gene". Genomics. 42 (3): 388–92.
doi:
10.1006/geno.1997.4769.
PMID9205109.
Sagara M, Takeda E, Nishiyama A, Utsumi S, Toyama Y, Yuasa S, Ninomiya Y, Imai T (Dec 2002). "Characterization of functional regions for nuclear localization of NPAT". Journal of Biochemistry. 132 (6): 875–9.
doi:
10.1093/oxfordjournals.jbchem.a003300.
PMID12473189.
Wang A, Ikura T, Eto K, Ota MS (Dec 2004). "Dynamic interaction of p220(NPAT) and CBP/p300 promotes S-phase entry". Biochemical and Biophysical Research Communications. 325 (4): 1509–16.
doi:
10.1016/j.bbrc.2004.10.198.
PMID15555599.
Kalla C, Scheuermann MO, Kube I, Schlotter M, Mertens D, Döhner H, Stilgenbauer S, Lichter P (May 2007). "Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B". European Journal of Cancer. 43 (8): 1328–35.
doi:
10.1016/j.ejca.2007.02.005.
PMID17449237.
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Imai T, Sugawara T, Nishiyama A, Shimada R, Ohki R, Seki N, Sagara M, Ito H, Yamauchi M, Hori T (Jun 1997). "The structure and organization of the human NPAT gene". Genomics. 42 (3): 388–92.
doi:
10.1006/geno.1997.4769.
PMID9205109.
Sagara M, Takeda E, Nishiyama A, Utsumi S, Toyama Y, Yuasa S, Ninomiya Y, Imai T (Dec 2002). "Characterization of functional regions for nuclear localization of NPAT". Journal of Biochemistry. 132 (6): 875–9.
doi:
10.1093/oxfordjournals.jbchem.a003300.
PMID12473189.
Wang A, Ikura T, Eto K, Ota MS (Dec 2004). "Dynamic interaction of p220(NPAT) and CBP/p300 promotes S-phase entry". Biochemical and Biophysical Research Communications. 325 (4): 1509–16.
doi:
10.1016/j.bbrc.2004.10.198.
PMID15555599.
Kalla C, Scheuermann MO, Kube I, Schlotter M, Mertens D, Döhner H, Stilgenbauer S, Lichter P (May 2007). "Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B". European Journal of Cancer. 43 (8): 1328–35.
doi:
10.1016/j.ejca.2007.02.005.
PMID17449237.